Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Nov 6, 2024Virtual Press Office and PR Newswire: General Trade show news
The only annual conference to focus on real-world voice AI applications and customer stories NEW YORK and LONDON, Nov. 6, 2024 /PRNewswire/ -- PolyAI, a global leader in voice AI solutions for...
-
Nov 6, 2024Virtual Press Office and PR Newswire: General Trade show news
Virtual Summit Runs from November 14-20, Featuring Four New Speakers Each Day FORT LAUDERDALE, Fla., Nov. 6, 2024 /PRNewswire/ -- Under the guidance of Life Coach and Energy Coach Daniel...
-
Nov 6, 2024Virtual Press Office and PR Newswire: General Trade show news
OS2000 IO-Link Communications Transceiver Improves Intelligence and Productivity for Industrial Applications MILPITAS, Calif., Nov. 6, 2024 /PRNewswire/ -- Orca Semiconductor today announced the...
-
Nov 6, 2024Virtual Press Office and PR Newswire: General Trade show news
Grant supports the expansion of their rapid, high-resolution LinkPrep™ technology in transforming cancer research SCOTTS VALLEY, Calif., Nov. 6, 2024 /PRNewswire/ -- Dovetail Genomics, a leading...
-
Nov 6, 2024Virtual Press Office and PR Newswire: General Trade show news
Sterling Infrastructure, Inc. (NasdaqGS: STRL) ("Sterling" or "the Company") today announced that management is participating in the following investor conferences: Baird Global Industrial...
-
Nov 6, 2024Virtual Press Office and PR Newswire: General Trade show news
Positive End of Phase 2 discussion with FDA, including alignment on Phase 3 design Bayley-4 expressive communication selected as Phase 3 study primary endpoint Initiation of ION582 Phase 3 study...
-
Nov 6, 2024Virtual Press Office and PR Newswire: General Trade show news
Bio-Techne Corporation (NASDAQ: TECH) today announced it will showcase its market-leading portfolio to advance cancer research from target discovery to personalized medicine and cell therapy...
-
Nov 6, 2024Virtual Press Office and PR Newswire: General Trade show news
Treatment with TPN-101 showed clinical benefits on key clinical outcome measures, including the Revised ALS Functional Rating Scale (ALSFRS-R) and Slow Vital Capacity (SVC) TPN-101 also had...
-
Nov 6, 2024Virtual Press Office and PR Newswire: General Trade show news
Flare Therapeutics Inc., a clinical-stage biotechnology company targeting transcription factors to discover precision medicines for oncology and other therapeutic areas, today announced that the...
-
Nov 6, 2024Virtual Press Office and PR Newswire: General Trade show news
Industry Veteran Raj Ananthanpillai will discuss how to identity, prevent and investigate insider threats to safeguard organizational assets and share best practices and compliance strategies...